Kutatási jelek – Signal Engine

• Randomized phase III trial of radiation therapy with or without pembrolizumab for women with high intermediate risk mismatch repair deficient endometrioid endometrial cancer (NRG-GY020) — Endometrial cancer
• STRO-002 Shows Early Efficacy and Safety in Heavily Pretreated Epithelial Ovarian Cancer — Ovarian cancer
• Leiomyosarcoma — Leiomyosarcoma
• Patricia Pautier, MD, on Leiomyosarcoma: Doxorubicin and Trabectedin for First-Line Treatment — Acute myeloid leukemia
• Clarifying Timing of Immunotherapy for Advanced Bladder Cancer — Bladder cancer
• Breakthrough study reveals gene drivers specific to Asian lung cancers — NSCLC
• Post Polycythemia Vera Myelofibrosis — Myelofibrosis
• A Clinical Trial Saved My Life — Cholangiocarcinoma
• Near-infrared fluorescence imaging with IndoCyanine Green for the intraoperative identification of Gastrointestinal stromal cell tumours: a pilot study — Gastrointestinal stromal tumor
• Glioblastoma Precision Medicine Program — Glioblastoma
• Adrenocortical Carcinoma Overview — Adrenocortical carcinoma
• Cervical Cancer Overview — Cervical cancer
• Breakthrough: FDA Approves First Treatment in 22 Years for a Common Type of Bladder Cancer — Bladder cancer
• FDA Grants Priority Review for Retifanlimab for Advanced Squamous Cell Carcinoma of the Anal Canal — Anal squamous cell carcinoma
• Waldenström Macroglobulinemia Treatment Moves Away From Chemotherapy — Waldenstrom macroglobulinemia
• Pancreatic cancer — Pancreatic cancer
• Maintenance pemetrexed after platinum pemetrexed chemotherapy and survival outcomes in malignant pleural mesothelioma in a multicenter real world study — Malignant pleural mesothelioma
• Increased neural excitability and glioma synaptic activity drives glioma proliferation in human cortex — Glioblastoma
• Trials 1/2020 — NSCLC
• Small Cell Lung Cancer Research Roundup: Promising Clinical Trial Updates — SCLC